The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2299-5684
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells ; day:30 ; month:7 ; year:2022 ; pages:1-13
Pharmacological reports ; (30.7.2022), 1-13
- Creator
-
Tam, Stanton
Al-Zubaidi, Yassir
Rahman, Md Khalilur
Bourget, Kirsi
Zhou, Fanfan
Murray, Michael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s43440-022-00396-7
- URN
-
urn:nbn:de:101:1-2022101720444454703361
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tam, Stanton
- Al-Zubaidi, Yassir
- Rahman, Md Khalilur
- Bourget, Kirsi
- Zhou, Fanfan
- Murray, Michael
- SpringerLink (Online service)
Other Objects (12)
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436
Tumorbiologische Effekte des Metastasierungssuppressors KAI1 und seiner Splice-Variante in humanen kultivierten MDA-MB-231- und MDA-MB-435-Zellen
Citral induced apoptosis in MDA-MB-231 spheroid cells
Antibacterial synthetic peptides derived from bovine lactoferricin exhibit cytotoxic effect against MDA-MB-468 and MDA-MB-231 breast cancer cell lines
Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells
Correction: Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells
Der A2B-Adenosinrezeptor und MAP-Kinase-Aktivität in MDA-MB-231-Brustkrebszellen
Effects of osteopontin inhibition on radiosensitivityof MDA-MB-231 breast cancer cells
Der A2B-Adenosinrezeptor und MAP-Kinase Aktivität in MDA-MB-231-Brustkrebszellen
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436
Tumorbiologische Effekte des Metastasierungssuppressors KAI1 und seiner Splice-Variante in humanen kultivierten MDA-MB-231- und MDA-MB-435-Zellen
Citral induced apoptosis in MDA-MB-231 spheroid cells
Antibacterial synthetic peptides derived from bovine lactoferricin exhibit cytotoxic effect against MDA-MB-468 and MDA-MB-231 breast cancer cell lines
Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells
Correction: Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells
Der A2B-Adenosinrezeptor und MAP-Kinase-Aktivität in MDA-MB-231-Brustkrebszellen
Effects of osteopontin inhibition on radiosensitivityof MDA-MB-231 breast cancer cells
Der A2B-Adenosinrezeptor und MAP-Kinase Aktivität in MDA-MB-231-Brustkrebszellen
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436
Tumorbiologische Effekte des Metastasierungssuppressors KAI1 und seiner Splice-Variante in humanen kultivierten MDA-MB-231- und MDA-MB-435-Zellen
Citral induced apoptosis in MDA-MB-231 spheroid cells
Antibacterial synthetic peptides derived from bovine lactoferricin exhibit cytotoxic effect against MDA-MB-468 and MDA-MB-231 breast cancer cell lines
Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells
Correction: Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells
Der A2B-Adenosinrezeptor und MAP-Kinase-Aktivität in MDA-MB-231-Brustkrebszellen
Effects of osteopontin inhibition on radiosensitivityof MDA-MB-231 breast cancer cells